Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Research article

The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study

Veronika Seebacher1*, Maximilian Schmid1, Stephan Polterauer1, Katrin Hefler-Frischmuth2, Heinz Leipold3, Nicole Concin4, Alexander Reinthaller1 and Lukas Hefler1

Author Affiliations

1 Department of Obstetrics & Gynecology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria

2 Department of Laboratory Medicine, Wilhelminenspital, Montleartstraße 37, 1160 Vienna, Austria

3 Department of Obstetrics & Gynecology, Landeskrankenhaus Klagenfurt, St. Veiter Strasse 47, 9020 Klagenfurt, Austria

4 Department of Obstetrics & Gynecology, Innsbruck Medical University, Christoph-Probst-Platz, Innrain 52, 6020 Innsbruck, Austria

For all author emails, please log on.

BMC Cancer 2009, 9:460  doi:10.1186/1471-2407-9-460

Published: 22 December 2009

Abstract

Background

To date, there is no consensus on the utility of screening procedures for the early detection of endometrial cancer. The value of transvaginal ultrasound for screening of asymptomatic endometrial cancer has been discussed controversially. This study was conducted to evaluate whether asymptomatic patients with endometrial cancer have a better prognosis than symptomatic patients with endometrial cancer diagnosed after postmenopausal bleeding.

Methods

In the present multi-center study, the effect of the presence of postmenopausal bleeding on prognosis was evaluated retrospectively in 605 patients with endometrial cancer using patients' files. 543 patients (133 patients were asymptomatic, 410 patients were symptomatic) with endometrioid endometrial cancer were enrolled in all further analysis. Student's t-test, Cox regression analysis and Kaplan-Meier analysis were used were appropriate.

Results

Presence/absence of a postmenopausal bleeding was not associated with tumor stage (p = 0.2) and age at diagnosis (p = 0.5). Asymptomatic patients with endometrial cancer had a significantly higher rate of well and moderate-differentiated tumors compared to symptomatic patients (p = 0.008). In univariable and multivariable survival analysis, tumor stage, tumor grade, and patients' age at diagnosis, but not presence/absence of a postmenopausal bleeding, were associated with disease free and overall survival.

Conclusion

Asymptomatic patients with endometrial cancer have a higher rate of well differentiated tumors compared to patients with a postmenopausal bleeding prior to diagnosis. The prognosis of both groups of patients was similar.